The HudsonAlpha Clinical
Services Lab, in collaboration with Illumina, serves as the whole genome sequencing
core for the Undiagnosed Disease Network (UDN), a National Institutes of
Health - funded study to diagnosed rare and new diseases through the
use of genomics and other advanced technologies.